Latest news and insights on the pharmaceutical industry | Indian Pharma Post | Page 6

Results For "population"

1013 News Found

GE HealthCare expands DeepHealth AI partnership to supercharge breast cancer detection
Medical Device | April 20, 2026

GE HealthCare expands DeepHealth AI partnership to supercharge breast cancer detection

The move aims to accelerate the development, commercialization, and global rollout of advanced AI-powered mammography tools


Inter-ministerial study to track zoonotic spillover risks in India
Public Health | April 17, 2026

Inter-ministerial study to track zoonotic spillover risks in India

One Health-based surveillance model to focus on bird sanctuaries and high-risk human populations


Kayentis and RWS partner to improve clinical trial data reliability in CNS studies
Digitisation | April 17, 2026

Kayentis and RWS partner to improve clinical trial data reliability in CNS studies

Integrated eCOA technology and rater training aim to reduce variability and strengthen ClinRO outcomes


Bayer flags major Phase III results for stroke prevention drug asundexian
Clinical Trials | April 17, 2026

Bayer flags major Phase III results for stroke prevention drug asundexian

The study evaluated asundexian (50 mg), a once-daily oral anticoagulant candidate, versus placebo—both given alongside standard antiplatelet therapy


C-mo wins CE Mark for AI-powered cough monitoring device, targets clinical trials market
News | April 16, 2026

C-mo wins CE Mark for AI-powered cough monitoring device, targets clinical trials market

The CE Mark builds on the company’s ISO 13485 certification, further strengthening confidence in the platform's safety, quality and performance


Teva launches Home Ground platform to tackle isolation in schizophrenia care
Digitisation | April 16, 2026

Teva launches Home Ground platform to tackle isolation in schizophrenia care

The online platform is designed to go beyond clinical treatment, offering practical tools, lived-experience insights, and peer-informed support intended to reduce isolation and improve day-to-day coping


India’s Biotech Moment: Eyestem CEO bets on fast-tracked cures & global breakthroughs
Biotech | April 16, 2026

India’s Biotech Moment: Eyestem CEO bets on fast-tracked cures & global breakthroughs

Dr Desai argued that the sector is undergoing a structural acceleration in how quickly science turns into treatments


FDA grants priority review to Daiichi Sankyo & Merck’s lung cancer drug application
Drug Approval | April 15, 2026

FDA grants priority review to Daiichi Sankyo & Merck’s lung cancer drug application

The investigational therapy, ifinatamab deruxtecan, is a potential first-in-class B7-H3 directed DXd antibody drug conjugate discovered by Daiichi Sankyo and jointly developed with Merck


WHO unites 800+ institutions in historic global health push to prepare for next pandemic threat
Public Health | April 14, 2026

WHO unites 800+ institutions in historic global health push to prepare for next pandemic threat

Scientists at the forum warned of an increasingly volatile health landscape